KR830007647A - 벤조헤테로사이클릭 화합물의 제조방법 - Google Patents

벤조헤테로사이클릭 화합물의 제조방법 Download PDF

Info

Publication number
KR830007647A
KR830007647A KR1019810004999A KR810004999A KR830007647A KR 830007647 A KR830007647 A KR 830007647A KR 1019810004999 A KR1019810004999 A KR 1019810004999A KR 810004999 A KR810004999 A KR 810004999A KR 830007647 A KR830007647 A KR 830007647A
Authority
KR
South Korea
Prior art keywords
compound
formula
process according
carried out
ring closure
Prior art date
Application number
KR1019810004999A
Other languages
English (en)
Other versions
KR880001634B1 (ko
Inventor
준이찌로 오쯔보
요시아끼 마나베
가즈유끼 나까가와
Original Assignee
오쯔까 아끼히꼬
오쯔까 세이야꾸 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55179949A external-priority patent/JPS57102887A/ja
Priority claimed from JP15245181A external-priority patent/JPS5855484A/ja
Application filed by 오쯔까 아끼히꼬, 오쯔까 세이야꾸 가부시끼 가이샤 filed Critical 오쯔까 아끼히꼬
Publication of KR830007647A publication Critical patent/KR830007647A/ko
Application granted granted Critical
Publication of KR880001634B1 publication Critical patent/KR880001634B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)

Abstract

내용 없음

Description

벤조 헤테로사이클릭 화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (23)

  1. 다음 일반식(Ⅱ)의 벤조헤테로사이클릭화합물을 폐환시키거나, 다음 일반식(Ⅲ)의 퀴놀린 화합물을 폐환시킨 후, 이 화합물을 가수분해시켜서 다음 일반식(Ⅰ)의 벤조헤테로사이클릭 화합물을 제조하는 방법.
    상기 일반식을 설명하면
    R1은 수소원자 또는 저급알킬기이며
    R2는 수소원자, 할로겐원자 또는 하이드록시기로 치환될 수 있는 저급알킬기이거나, 할로겐원자로 치환될 수 있는 저급알카노일기이며
    R3및 R4는 같거나 다르며, 이들 각각은 저급알킬기이며(단, n 이 1일 경우 R2는 할로겐원자로 치환된 저급알킬기가 아니어야 한다).
    R5는 상기 일반식(Ⅳ)의 벤조헤테로사이클릭화합물을 형성시킬 수 있는 저급알킬기이며
    X는 수소원자 또는 할로겐원자이며
    n은 1 또는 2이다(단, n이 1일 경우, R2는 할로겐원자로 치환된 저급알킬기가 아니어야 한다).
  2. 제1항에 있어서, 용매중에 일반식(Ⅱ) 또는 (Ⅲ)의 화합물을 약 100 내지 250℃온도로 가열시켜 폐환을 수행하는 상기 방법.
  3. 제2항에 있어서, 반응을 150 내지 200℃에서 수행하는 상기 방법.
  4. 제2항 또는 제3항에 있어서, 용매가 고비점 탄화수소 또는 고비점 에테르인 상기 방법.
  5. 제4항에 있어서, 용매가 테트라린, 디페닐에테르 또는 디에틸렌 글리콜 디메틸에테르인 상기 방법.
  6. 제1항에 있어서, 일반식(Ⅱ) 또는 (Ⅲ)화합물을 몰당 적어도 1몰의 과량의 산성 지지물을 사용하여 폐환을 약 100 내지 150℃에서 약 0.5 내지 6시간 동안 수행하는 상기 방법.
  7. 제6항에 있어서, 산성 지지물의 양이 일반식(Ⅱ) 또는 화합물의 몰당 10 내지 20몰인 상기 방법.
  8. 제6항 또는 7항에 있어서, 산성 지지물이 포스포러스옥시클로라이드, 포스포러스 펜타클로라이드, 포스포러스트리클로라이드, 염화티오닐, 농황산 또는 폴리포스포러스산인 상기 방법.
  9. 제1항, 제2항, 제3항, 제4항, 제5항, 제6항, 제7항 또는 제8항중 어느 한 항에 있어서, 가수분해를 촉매 존재하에 실온 내지 200℃에서 수행하는 상기 방법.
  10. 제9항에 있어서, 가수분해를 50 내지 150℃에서 수행하는 상기 방법.
  11. 제9항 또는 제10항에 있어서 촉매가 염기성화합물인 상기 방법.
  12. 제9항 또는 제10항에 있어서, 촉매가 광산 또는 유기산인 상기 방법.
  13. 제9항, 제10항, 제11항 또는 제12항에 있어서, 가수분해가 용매중에 수행되는 상기 방법.
  14. 제1항에 있어서, 일반식(Ⅰ)의 벤조헤테로사이클릭 화합물이 일반식(Ⅱ)의 벤조헤테로사이클릭 화합물을 폐환시켜 제조되는 상기 방법.
  15. 제1항에 있어서, 일반식(Ⅰ)의 벤조헤테로사이클릭 화합물이 일반식(Ⅱ)의 벤조헤테로사이클릭 화합물을 폐환시켜 제조되는 상기 방법.
  16. 제14항에 있어서, 용매중에 일반식(Ⅱ)의 화합물을 약 100 내지 250℃ 온도로 가열시켜 폐환을 수행하는 상기 방법.
  17. 제14항에 있어서, 반응을 150 내지 200℃에서 수행하는 상기 방법.
  18. 제14항에 있어서, 일반식(Ⅱ) 화합물의 몰당 적어도 1몰의 과량의 산성 지지몰을 사용하여 폐환을 약 100 내지 150℃에서 수행하는 상기 방법.
  19. 제14항에 있어서, 산성 지지물의 양이 일반식(Ⅱ)화합물의 몰당 10 내지 20몰인 상기 방법.
  20. 제15항에 있어서, 용매중에 일반식(Ⅲ)화합물을 약 100 내지 250℃ 온도로 가열시켜 폐환을 수행하는 상기 방법.
  21. 제15항에 있어서, 반응을 150 내지 200℃에서 수행하는 상기 방법.
  22. 제15항에 있어서, 일반식(Ⅲ)화합물의 몰당 적어도 1몰의 과량의 산성 지지물을 사용하여 폐환을 약 100 내지 150℃에서 약 0.5 내지 6시간동안 수행하는 상기 방법.
  23. 제15항에 있어서, 산성 지지물의 양이 일반식(Ⅲ) 화합물의 몰당 10 내지 20몰인 상기 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019810004999A 1980-12-18 1981-12-17 벤조 헤테로사이클릭 화합물의 제조방법 KR880001634B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP55179949A JPS57102887A (en) 1980-12-18 1980-12-18 Preparation of benzo(ij)quinolizine-2-carboxylic acid derivative
JP179949 1980-12-18
JP152451/81 1981-09-25
JP15245181A JPS5855484A (ja) 1981-09-25 1981-09-25 ピロロ〔3,2,1−「あい」「じえゞ」〕キノリン−5−カルボン酸誘導体の製造法
JP152451 1981-09-25

Publications (2)

Publication Number Publication Date
KR830007647A true KR830007647A (ko) 1983-11-04
KR880001634B1 KR880001634B1 (ko) 1988-09-03

Family

ID=26481369

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810004999A KR880001634B1 (ko) 1980-12-18 1981-12-17 벤조 헤테로사이클릭 화합물의 제조방법

Country Status (9)

Country Link
KR (1) KR880001634B1 (ko)
AR (1) AR231723A1 (ko)
AT (1) AT380250B (ko)
CA (1) CA1183535A (ko)
ES (1) ES508647A0 (ko)
FR (1) FR2496662B1 (ko)
GB (1) GB2091726B (ko)
PT (1) PT74145B (ko)
SU (1) SU1428201A3 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
US4472406A (en) * 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-8-(imidazol-1-yl)-5-methyl-1-oxo-1H,5H-benzo [ij]quinolizine-2-carboxylic acids and derivatives
JPS59137482A (ja) * 1983-01-26 1984-08-07 Otsuka Pharmaceut Co Ltd ピロロ〔3,2,1,−ij〕キノリン−5−カルボン酸誘導体
JPS59155381A (ja) * 1983-02-22 1984-09-04 Kyorin Pharmaceut Co Ltd ベンゾキノリジンカルボン酸誘導体及びその製造法
ATE81975T1 (de) * 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
EP0185429A1 (en) * 1984-12-21 1986-06-25 Duphar International Research B.V New bicyclic heteroaryl piperazines
AU585981B2 (en) * 1985-05-24 1989-06-29 Tokyo Tanabe Company Limited Benzo (IJ) quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and processes for preparing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793524A (fr) * 1971-12-30 1973-06-29 Riker Laboratories Inc Acides benzoquinolizine-carboxyliques et leurs derives
DE2914258A1 (de) * 1978-04-12 1979-10-25 Otsuka Pharma Co Ltd Piperazinylbenzoheterozyklische verbindungen, verfahren zu deren herstellung und mittel, welche diese enthalten

Also Published As

Publication number Publication date
SU1428201A3 (ru) 1988-09-30
ES8304972A1 (es) 1983-04-01
KR880001634B1 (ko) 1988-09-03
AR231723A1 (es) 1985-02-28
FR2496662A1 (fr) 1982-06-25
PT74145B (en) 1983-05-30
PT74145A (en) 1982-01-01
FR2496662B1 (fr) 1985-07-26
AT380250B (de) 1986-04-25
ES508647A0 (es) 1983-04-01
ATA540181A (de) 1985-09-15
GB2091726B (en) 1985-02-20
CA1183535A (en) 1985-03-05
GB2091726A (en) 1982-08-04

Similar Documents

Publication Publication Date Title
KR870003989A (ko) 치환 및 이치환 피리딘-2,3-디카르복실레이트의 제조방법과 치환된 니코티네이트의 제조방법
KR840009063A (ko) 펜에타놀아민 유도체 제조방법
KR850003890A (ko) 1H-이미다조[4,5c]-퀴놀린-4-아민의 제조방법
KR850001199A (ko) 1,8-나프티리딘 유도체의 제조법
KR840005450A (ko) 말론산에스테르의 이성화 방법
KR860004025A (ko) 퀴놀론 카복실산의 제조방법
KR840004102A (ko) 퀴놀린 화합물의 제조방법
KR840000508A (ko) 4-아닐리노피리미딘 유도체의 제조방법
KR830007647A (ko) 벤조헤테로사이클릭 화합물의 제조방법
KR940703807A (ko) 22-옥사콜레칼시페롤 유도체 및 그의 제조방법(22-oxacholecalciferol derivative and production thereof)
KR860001065A (ko) 4-아세톡시-3-히드록시에틸아제티진-2-온유도체의 제조방법
KR840001555A (ko) 치환된 2-페닐-2-(피리딜욕시)-에틸아민과 그의 등 배전자화합물 및 그들의 산부가염을 제조하는 방법
KR840006476A (ko) 3-페녹시벤질 2-(4-알콕시페닐)-2-메틸프로필 에테르의 제조방법
KR890701564A (ko) 퀴놀린 카복실산 유도체를 제조하는 방법
KR860008135A (ko) 아미노케톤 유도체의 제조방법
KR870002069A (ko) 2-(3,5-디알킬-4-히드록시페닐) 인돌 유도체의 제조방법
KR830007554A (ko) 인돌리논의 제조방법
KR830004320A (ko) 퀴나졸린 유도체의 제조방법
KR860001073A (ko) 이미다졸린의 제조방법
KR840005723A (ko) 티아졸유도체의 제조방법
KR900011751A (ko) 선택적 에테르화 반응
KR900014355A (ko) 티오펜-2,5-디카르복실산디에스테르, 테트라하이드로티오펜-2,5-디카르복실산디에스테르 및 디벤즈옥사졸일 티오펜의 제조방법
KR830007639A (ko) 락탐 화합물의 제조방법
KR840005107A (ko) 피리미디온 및 그의 산부가염의 제조방법
KR840000551A (ko) 이미다조[1, 2-a]피리미딘의 제조방법